Breast Cancer

The deal allows Biocon to launch the biosimilar in the EU and the UK from the Q1 of 2027, and in the US from the Q3 of 2028

Updated On: 14 Oct 2026 | 11:00 PM IST

Biocon's Pertuzumab has received a positive EMA CHMP recommendation, becoming the first biosimilar to clear the agency's new tailored clinical development approach for HER2-positive breast cancer

Updated On: 21 Sep 2026 | 10:39 AM IST

The company expects the decentralised model to at least double its annual testing volume to around 6,000 from the current 3,000

Updated On: 07 Sep 2026 | 11:37 PM IST

Bengaluru company expects annual volumes to double as decentralised test lowers logistical barriers to personalised treatment

Updated On: 04 Sep 2026 | 4:44 PM IST

The latest global analysis shows breast cancer cases rising fastest in lower-income nations, while India records a dramatic increase in both incidence and mortality

Updated On: 03 Mar 2026 | 4:56 PM IST

The review highlights how changes in immune cells inside tumours may speed up breast cancer spread and could shape future treatment strategies

Updated On: 12 Feb 2026 | 2:18 PM IST

A large Swedish trial published in The Lancet suggests AI-supported mammography can detect more breast cancers earlier and reduce aggressive interval cancers, without replacing radiologists

Updated On: 03 Feb 2026 | 9:00 AM IST

From bras and breastfeeding to lump anxiety and radiation fears, doctors break down the myths that stop men and women alike from getting timely breast cancer screening

Updated On: 07 Nov 2025 | 1:45 PM IST

Can young women or men get breast cancer? Are mammograms unsafe? In this episode of our fact-check series, doctors debunk the biggest breast health myths and explain why regular screening saves lives.

Updated On: 07 Nov 2025 | 11:23 AM IST
Icon Youtube

Why do myths, modesty and misinformation still overshadow one of medicine's best defences against breast cancer? Experts say it is time to make mammograms as routine as blood pressure checks

Updated On: 31 Oct 2025 | 11:36 AM IST

Breast cancer affects men too, yet most don't know the symptoms. Experts explain warning signs, risks, and why awareness matters

Updated On: 30 Oct 2025 | 3:59 PM IST

Breast cancer is rising among women under 40, with aggressive subtypes becoming more common. Experts urge early awareness, genetic testing, and regular breast self-exams

Updated On: 30 Oct 2025 | 12:45 PM IST

Breast cancer awareness: Simple, safe and empowering, regular breast self-exams help you stay one step ahead of potential changes that could signal a cancer risk

Updated On: 28 Oct 2025 | 5:34 PM IST

Breast cancer awareness: Inherited risk explains only a fraction of breast cancer cases. Regular exercise, balanced nutrition and stress control help protect women's health and support prevention

Updated On: 27 Oct 2025 | 4:06 PM IST

Women's cancers like breast, cervical, and ovarian are often detected late in poorer countries, sharply reducing survival chances, according to a global Lancet study

Updated On: 23 Oct 2025 | 12:27 PM IST

Scientists find that high-fat diets and elevated lipid levels can accelerate breast cancer growth, prompting caution over keto regimens among patients and survivors

Updated On: 21 Oct 2025 | 3:14 PM IST

Researchers have developed an AI model that not only detects breast cancer with near-perfect accuracy but also visually explains its diagnosis to doctors, improving trust and transparency in screening

Updated On: 14 Oct 2025 | 1:46 PM IST

Breast cancer awareness month 2025: Cases of invasive lobular carcinoma are increasing nearly three times faster than other breast cancers, raising alarm over detection, diagnosis, and treatment gaps

Updated On: 10 Oct 2025 | 3:42 PM IST

Alkem Laboratories on Monday said it has launched a biosimilar product in India for the treatment of breast cancer. The company has introduced Pertuza injection 420mg/14mL, a pertuzumab biosimilar, for the treatment of HER2-positive breast cancer, the drug firm said in a statement. Alkem's Pertuza is an affordable, indigenously-developed and manufactured biosimilar of pertuzumab, it added. "Oncology is a priority area for Alkem, and our efforts are focused on developing treatment options that combine scientific excellence with wider access. The launch of Pertuza reflects this commitment and further strengthens our oncology portfolio," Alkem CEO Vikas Gupta said. Shares of the company on Monday ended 0.69 per cent down at Rs 5,496 apiece on BSE.

Updated On: 22 Sep 2025 | 8:07 PM IST

Just one bout of high-intensity or resistance training can cut breast cancer cell growth by up to 30 per cent by boosting anti-cancer proteins, say researchers

Updated On: 16 Sep 2025 | 12:55 PM IST